BIO Protocol (BIO) arrives as an innovative proposal that connects blockchain with biotechnology to drive decentralized science (DeSci). Launched on Ethereum, BIO raised $64.41 million in its initial public sale, generating great expectations in the market.
However, after its debut, BIO faced significant challenges:
• Price drop: Its initial value of $1.477 USDT fell by 45.8%, reaching $0.8 USDT.
• Scams: Fraudulent tokens appeared on other blockchains and fake links on Telegram.
• Official warnings: The team clarified that BIO only operates on the Ethereum mainnet.
What’s next for BIO?
Despite the issues, BIO has potential in a competitive market like DeSci. However, its future will depend on overcoming volatility and ensuring safety for investors.
Will this be the crypto that will revolutionize biotechnology? Time will tell.